Cellumed Co Ltd (049180)

KOSDAQ
Currency in KRW
871
-26(-2.90%)
Closed·
049180 Scorecard
Full Analysis
Suffers from weak gross profit margins
049180 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
867907
52 wk Range
8504,415
Key Statistics
Edit
Bid/Ask
871.00 / 873.00
Prev. Close
897
Open
898
Day's Range
867-907
52 wk Range
850-4,415
Volume
149.37K
Average Volume (3m)
577.13K
1-Year Change
-45.96%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
049180 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Prominent player in the Healthcare Equipment & Supplies industry
No news in this category
Looks like there are no results in this news category

Cellumed Company Profile

Cellumed Co.,Ltd., a biotechnology company, provides bone graft materials, medical devices, and cosmeceuticals in South Korea. The company offers CLnZyme, a mRNA enzyme; cosmeceuticals, such as FGF7 for skin regeneration and TGFß-1 for tissue regeneration; and electric motorcycles. It provides tissue bank products, such as celluderm powder, ultra, and HD implant for the skin; patellar tendon hemi whole, posterior tibialis, anterior tibialis, semitendinosus, gracilis, and peroneus longus tendons, and meniscus lateral and medial; cancellous bone chips and cortical cancellous dental bone powders; and femoral, tibia, radius, and ulna shafts, femur distal, tibia proximal, and cervical spacer bones. In addition, the company offers medical devices for tissue regeneration, such as Rafugen DBM Gel Pro, Bio BMP2, BIOFIX SCREW, BIO MENISCUS GRAFT, SOLID W6, and viscoseal syringe; and joint reconstruction, comprising luminus flex total knee system fixed and mobile type and luminus flex patient specific instruments. Further, it is involved in biopharmaceutical development; construction machinery; food handling; and sales and brokerage of travel products. The company was formerly known as Korea Bone Bank Co., Ltd. and changed its name to Cellumed Co.,Ltd. in April 2013. Cellumed Co.,Ltd. was founded in 1985 and is headquartered in Seoul, South Korea.

Compare 049180 to Peers and Sector

Metrics to compare
049180
Peers
Sector
Relationship
P/E Ratio
−1.6x−3.0x−0.4x
PEG Ratio
−0.06−0.310.00
Price/Book
5.6x1.3x2.6x
Price / LTM Sales
0.4x6.2x2.9x
Upside (Analyst Target)
-59.5%53.5%
Fair Value Upside
Unlock−5.1%9.5%Unlock

Earnings

Latest Release
Mar 21, 2025
EPS / Forecast
-501.08 / --
Revenue / Forecast
36.63B / --
EPS Revisions
Last 90 days

FAQ

What Is the Cellumed (049180) Stock Price Today?

The Cellumed stock price today is 871.00.

What Stock Exchange Does Cellumed Trade On?

Cellumed is listed and trades on the KOSDAQ stock exchange.

What Is the Stock Symbol for Cellumed?

The stock symbol for Cellumed is "049180."

What Is the Cellumed Market Cap?

As of today, Cellumed market cap is 49.29B.

What Is Cellumed's Earnings Per Share (TTM)?

The Cellumed EPS (TTM) is -648.25.

From a Technical Analysis Perspective, Is 049180 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Cellumed Stock Split?

Cellumed has split 11 times.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.